Your Input: | |||||
A306_00015172 | F-box/WD repeat-containing protein 7. (357 aa) | ||||
A306_00014960 | RanBP-type and C3HC4-type zinc finger-containing protein 1-like. (681 aa) | ||||
PPP2R1A | Protein phosphatase 2, regulatory subunit A, alpha. (503 aa) | ||||
HTRA2 | HtrA serine peptidase 2. (253 aa) | ||||
PEA15 | Phosphoprotein enriched in astrocytes 15. (158 aa) | ||||
PLAGL2 | Pleiomorphic adenoma gene-like 2. (493 aa) | ||||
LCK | Tyrosine-protein kinase. (501 aa) | ||||
PIAS4 | Protein inhibitor of activated STAT, 4. (485 aa) | ||||
NGFR | Nerve growth factor receptor. (276 aa) | ||||
TRAF7 | TNF receptor-associated factor 7, E3 ubiquitin protein ligase. (670 aa) | ||||
TP63 | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. (680 aa) | ||||
APAF1 | Apoptotic protease-activating factor 1; Oligomeric Apaf-1 mediates the cytochrome c-dependent autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the activation of caspase-3 and apoptosis. This activation requires ATP. (1248 aa) | ||||
PAK2 | Non-specific serine/threonine protein kinase. (525 aa) | ||||
ITM2C | Integral membrane protein 2C, transcript variant X1. (217 aa) | ||||
CRADD | CASP2 and RIPK1 domain containing adaptor with death domain. (197 aa) | ||||
FBXW7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase. (487 aa) | ||||
FAS | Fas cell surface death receptor. (399 aa) | ||||
FAF1 | Fas (TNFRSF6) associated factor 1. (733 aa) | ||||
INHBA | Inhibin, beta A. (424 aa) | ||||
G0S2 | G0/G1 switch 2. (99 aa) | ||||
FLCN | Folliculin. (579 aa) | ||||
GPER1 | G protein-coupled estrogen receptor 1; Belongs to the G-protein coupled receptor 1 family. (357 aa) | ||||
CTSC | Cathepsin C; Belongs to the peptidase C1 family. (475 aa) | ||||
STYXL1 | Serine/threonine/tyrosine interacting-like 1. (335 aa) | ||||
CYLD | Cylindromatosis (Turban tumor syndrome); Belongs to the peptidase C19 family. (949 aa) | ||||
RPS3 | Ribosomal protein S3; Belongs to the universal ribosomal protein uS3 family. (243 aa) | ||||
AGTR2 | Angiotensin II receptor, type 2; Belongs to the G-protein coupled receptor 1 family. (372 aa) | ||||
TGFBR1 | Receptor protein serine/threonine kinase; Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily. (503 aa) | ||||
SRPX | Sushi-repeat containing protein, X-linked. (494 aa) | ||||
A306_00006775 | Protein PML. (586 aa) | ||||
A306_00006777 | Protein PML. (739 aa) | ||||
PDIA3 | Protein disulfide-isomerase. (463 aa) | ||||
PLEKHF1 | Pleckstrin homology domain containing, family F (With FYVE domain) member 1. (273 aa) | ||||
WWOX | WW domain containing oxidoreductase. (338 aa) | ||||
BMPR1B | Receptor protein serine/threonine kinase; Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily. (502 aa) | ||||
ATF3 | Activating transcription factor 3, transcript variant X1. (218 aa) | ||||
SKIL | SKI-like proto-oncogene. (690 aa) | ||||
TNFSF10 | Tumor necrosis factor (Ligand) superfamily, member 10; Belongs to the tumor necrosis factor family. (194 aa) | ||||
CTSH | Cathepsin H; Belongs to the peptidase C1 family. (259 aa) | ||||
BCL10 | B-cell CLL/lymphoma 10. (214 aa) | ||||
PTPRC | Protein tyrosine phosphatase, receptor type, C, transcript variant X1. (1247 aa) | ||||
SIRT1 | Sirtuin 1, transcript variant X1. (606 aa) | ||||
INHBB | Inhibin, beta B. (305 aa) | ||||
FADD | Fas (TNFRSF6)-associated via death domain. (195 aa) | ||||
ZSWIM2 | Zinc finger, SWIM-type containing 2. (566 aa) | ||||
DNM1L | Dynamin 1-like, transcript variant X3; Belongs to the TRAFAC class dynamin-like GTPase superfamily. Dynamin/Fzo/YdjA family. (700 aa) | ||||
TIMP3 | TIMP metallopeptidase inhibitor 3. (212 aa) | ||||
BCL2L14 | BCL2-like 14 (Apoptosis facilitator). (380 aa) | ||||
BID | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. (191 aa) | ||||
CASP2 | Caspase 2, apoptosis-related cysteine peptidase, transcript variant X1; Belongs to the peptidase C14A family. (426 aa) | ||||
MSX1 | Msh homeobox 1. (210 aa) | ||||
THBS1 | Thrombospondin 1. (997 aa) | ||||
DFNA5 | Deafness, autosomal dominant 5. (366 aa) | ||||
NCK2 | Cytoplasmic protein. (380 aa) | ||||
IL20RA | Interleukin 20 receptor, alpha. (550 aa) | ||||
BCLAF1 | BCL2-associated transcription factor 1, transcript variant X1. (920 aa) | ||||
TPD52L1 | Tumor protein D52-like 1, transcript variant X2. (181 aa) | ||||
AGT | Angiotensinogen (Serpin peptidase inhibitor, clade A, member 8); Belongs to the serpin family. (463 aa) | ||||
PTPN2 | Tyrosine-protein phosphatase non-receptor type. (408 aa) | ||||
RIPK1 | Receptor (TNFRSF)-interacting serine-threonine kinase 1. (685 aa) | ||||
A306_00001162 | Ubiquitin carboxyl-terminal hydrolase CYLD. (823 aa) |